Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
EvolveImmune United, Inc
OncoC4, Inc.
Seagen Inc.
Pfizer
IDEAYA Biosciences
Arcus Biosciences, Inc.
Sotio Biotech Inc.
Eli Lilly and Company
Pfizer
Rondo Therapeutics
BeOne Medicines
ViroMissile, Inc.
Tizona Therapeutics, Inc
Pilatus Biosciences Inc
Baylor College of Medicine
Jonsson Comprehensive Cancer Center
MacroGenics
City of Hope Medical Center
University Health Network, Toronto
NeoTX Therapeutics Ltd.
Actym Therapeutics, Inc.
Jonsson Comprehensive Cancer Center
Incyte Corporation
Toray Industries, Inc
Trishula Therapeutics, Inc.
Incyte Corporation
Genentech, Inc.
Trishula Therapeutics, Inc.
Monopar Therapeutics
Monopar Therapeutics
Black Diamond Therapeutics, Inc.
Revolution Medicines, Inc.
Seagen Inc.
National Cancer Institute (NCI)
Carisma Therapeutics Inc
Acepodia Biotech, Inc.
Shanghai PerHum Therapeutics Co., Ltd.
Keythera (Suzhou) Pharmaceuticals Co. Ltd
Eli Lilly and Company
Xencor, Inc.
ADC Therapeutics S.A.
Five Prime Therapeutics, Inc.
Arcus Biosciences, Inc.
Pfizer
STCube, Inc.
Zhejiang University
Celon Pharma SA
Adaptimmune